Call us : 1800 103 7100
Mail us : info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

ASCO: Bendamustine Held Superior to CHOP in Patients With Follicular, Indolent … – Cancer Network

June 11, 2012Monoclonal Anti-CD20 Antibodiesadmin

ASCO: Bendamustine Held Superior to CHOP in Patients With Follicular, Indolent ...
Cancer Network
By Michael Kaufman | June 12, 2012 CHICAGO—The two-drug combination of bendamustine (Treanda) plus rituximab (Rituxan) is more effective and less toxic than the standard CHOP regimen—cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), ...

Post navigation

← Family of deceased 46-year-old donates 7 organs – Jerusalem Post Sailor's Kidney Saves Teen's Life →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Hosted and managed by www.medindindia.net